vs
Genuine Parts Company（GPC）与汉瑞祥（HSIC）财务数据对比。点击上方公司名可切换其他公司
Genuine Parts Company的季度营收约是汉瑞祥的1.8倍（$6.3B vs $3.4B），Genuine Parts Company净利率更高（3.0% vs 2.9%，领先0.1%），汉瑞祥同比增速更快（7.7% vs 6.8%），汉瑞祥自由现金流更多（$338.0M vs $-33.6M），过去两年汉瑞祥的营收复合增速更高（4.1% vs 2.5%）
Genuine Parts Company（简称GPC）是总部位于美国佐治亚州亚特兰大的汽车及工业零部件分销商，1928年由卡莱尔与马尔科姆·弗雷泽兄弟创立，现有约6万名员工，业务覆盖美国、澳大拉西亚、欧洲、墨西哥等十余个国家和地区。
汉瑞祥（Henry Schein, Inc.）是美国的医疗保健产品及服务分销商，业务覆盖全球33个国家和地区，是全球面向诊所类牙科及医疗从业者的最大医疗解决方案供应商。公司连续14年入选Ethisphere评选的「全球最具道德企业」榜单，2025年再次登榜。
GPC vs HSIC — 直观对比
营收规模更大
GPC
是对方的1.8倍
$3.4B
营收增速更快
HSIC
高出0.9%
6.8%
净利率更高
GPC
高出0.1%
2.9%
自由现金流更多
HSIC
多$371.6M
$-33.6M
两年增速更快
HSIC
近两年复合增速
2.5%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $6.3B | $3.4B |
| 净利润 | $188.5M | $101.0M |
| 毛利率 | 37.3% | 30.9% |
| 营业利润率 | — | 4.7% |
| 净利率 | 3.0% | 2.9% |
| 营收同比 | 6.8% | 7.7% |
| 净利润同比 | -3.0% | 7.4% |
| 每股收益（稀释后） | $1.37 | $0.85 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GPCHSIC
| Q1 26 | $6.3B | — | ||
| Q4 25 | $6.0B | $3.4B | ||
| Q3 25 | $6.3B | $3.3B | ||
| Q2 25 | $6.2B | $3.2B | ||
| Q1 25 | $5.9B | $3.2B | ||
| Q4 24 | $5.8B | $3.2B | ||
| Q3 24 | $6.0B | $3.2B | ||
| Q2 24 | $6.0B | $3.1B |
净利润GPCHSIC
| Q1 26 | $188.5M | — | ||
| Q4 25 | $-609.5M | $101.0M | ||
| Q3 25 | $226.2M | $101.0M | ||
| Q2 25 | $254.9M | $86.0M | ||
| Q1 25 | $194.4M | $110.0M | ||
| Q4 24 | $133.1M | $94.0M | ||
| Q3 24 | $226.6M | $99.0M | ||
| Q2 24 | $295.5M | $104.0M |
毛利率GPCHSIC
| Q1 26 | 37.3% | — | ||
| Q4 25 | 35.0% | 30.9% | ||
| Q3 25 | 37.4% | 30.7% | ||
| Q2 25 | 37.7% | 31.4% | ||
| Q1 25 | 37.1% | 31.6% | ||
| Q4 24 | 35.9% | 31.1% | ||
| Q3 24 | 36.8% | 31.3% | ||
| Q2 24 | 36.6% | 32.5% |
营业利润率GPCHSIC
| Q1 26 | — | — | ||
| Q4 25 | -13.8% | 4.7% | ||
| Q3 25 | 4.7% | 4.9% | ||
| Q2 25 | 5.5% | 4.7% | ||
| Q1 25 | 4.3% | 5.5% | ||
| Q4 24 | 2.9% | 4.9% | ||
| Q3 24 | 5.0% | 4.9% | ||
| Q2 24 | 6.5% | 5.1% |
净利率GPCHSIC
| Q1 26 | 3.0% | — | ||
| Q4 25 | -10.1% | 2.9% | ||
| Q3 25 | 3.6% | 3.0% | ||
| Q2 25 | 4.1% | 2.7% | ||
| Q1 25 | 3.3% | 3.5% | ||
| Q4 24 | 2.3% | 2.9% | ||
| Q3 24 | 3.8% | 3.1% | ||
| Q2 24 | 5.0% | 3.3% |
每股收益（稀释后）GPCHSIC
| Q1 26 | $1.37 | — | ||
| Q4 25 | $-4.38 | $0.85 | ||
| Q3 25 | $1.62 | $0.84 | ||
| Q2 25 | $1.83 | $0.70 | ||
| Q1 25 | $1.40 | $0.88 | ||
| Q4 24 | $0.96 | $0.75 | ||
| Q3 24 | $1.62 | $0.78 | ||
| Q2 24 | $2.11 | $0.80 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $500.0M | $156.0M |
| 总债务越低越好 | $4.6B | $2.3B |
| 股东权益账面价值 | $4.5B | $3.2B |
| 总资产 | $21.0B | $11.2B |
| 负债/权益比越低杠杆越低 | 1.03× | 0.71× |
8季度趋势，按日历期对齐
现金及短期投资GPCHSIC
| Q1 26 | $500.0M | — | ||
| Q4 25 | — | $156.0M | ||
| Q3 25 | — | $136.0M | ||
| Q2 25 | — | $145.0M | ||
| Q1 25 | — | $127.0M | ||
| Q4 24 | — | $122.0M | ||
| Q3 24 | — | $126.0M | ||
| Q2 24 | — | $138.0M |
总债务GPCHSIC
| Q1 26 | $4.6B | — | ||
| Q4 25 | $4.8B | $2.3B | ||
| Q3 25 | — | $2.2B | ||
| Q2 25 | — | $2.1B | ||
| Q1 25 | — | $2.0B | ||
| Q4 24 | $4.3B | $1.8B | ||
| Q3 24 | — | $1.9B | ||
| Q2 24 | — | $1.9B |
股东权益GPCHSIC
| Q1 26 | $4.5B | — | ||
| Q4 25 | $4.4B | $3.2B | ||
| Q3 25 | $4.8B | $3.4B | ||
| Q2 25 | $4.7B | $3.4B | ||
| Q1 25 | $4.4B | $3.3B | ||
| Q4 24 | $4.3B | $3.4B | ||
| Q3 24 | $4.7B | $3.5B | ||
| Q2 24 | $4.5B | $3.5B |
总资产GPCHSIC
| Q1 26 | $21.0B | — | ||
| Q4 25 | $20.8B | $11.2B | ||
| Q3 25 | $20.7B | $11.1B | ||
| Q2 25 | $20.4B | $10.9B | ||
| Q1 25 | $19.8B | $10.5B | ||
| Q4 24 | $19.3B | $10.2B | ||
| Q3 24 | $20.3B | $10.6B | ||
| Q2 24 | $18.9B | $10.3B |
负债/权益比GPCHSIC
| Q1 26 | 1.03× | — | ||
| Q4 25 | 1.08× | 0.71× | ||
| Q3 25 | — | 0.64× | ||
| Q2 25 | — | 0.61× | ||
| Q1 25 | — | 0.59× | ||
| Q4 24 | 0.99× | 0.54× | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | — | 0.54× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $381.0M |
| 自由现金流经营现金流 - 资本支出 | $-33.6M | $338.0M |
| 自由现金流率自由现金流/营收 | -0.5% | 9.8% |
| 资本支出强度资本支出/营收 | — | 1.3% |
| 现金转化率经营现金流/净利润 | — | 3.77× |
| 过去12个月自由现金流最近4个季度 | $548.0M | $573.0M |
8季度趋势，按日历期对齐
经营现金流GPCHSIC
| Q1 26 | — | — | ||
| Q4 25 | $380.1M | $381.0M | ||
| Q3 25 | $341.6M | $174.0M | ||
| Q2 25 | $209.9M | $120.0M | ||
| Q1 25 | $-40.8M | $37.0M | ||
| Q4 24 | $155.0M | $204.0M | ||
| Q3 24 | $484.3M | $151.0M | ||
| Q2 24 | $293.6M | $296.0M |
自由现金流GPCHSIC
| Q1 26 | $-33.6M | — | ||
| Q4 25 | $260.7M | $338.0M | ||
| Q3 25 | $240.0M | $141.0M | ||
| Q2 25 | $81.0M | $88.0M | ||
| Q1 25 | $-160.7M | $6.0M | ||
| Q4 24 | $-26.7M | $168.0M | ||
| Q3 24 | $358.0M | $117.0M | ||
| Q2 24 | $150.1M | $259.0M |
自由现金流率GPCHSIC
| Q1 26 | -0.5% | — | ||
| Q4 25 | 4.3% | 9.8% | ||
| Q3 25 | 3.8% | 4.2% | ||
| Q2 25 | 1.3% | 2.7% | ||
| Q1 25 | -2.7% | 0.2% | ||
| Q4 24 | -0.5% | 5.3% | ||
| Q3 24 | 6.0% | 3.7% | ||
| Q2 24 | 2.5% | 8.3% |
资本支出强度GPCHSIC
| Q1 26 | — | — | ||
| Q4 25 | 2.0% | 1.3% | ||
| Q3 25 | 1.6% | 1.0% | ||
| Q2 25 | 2.1% | 1.0% | ||
| Q1 25 | 2.0% | 1.0% | ||
| Q4 24 | 3.1% | 1.1% | ||
| Q3 24 | 2.1% | 1.1% | ||
| Q2 24 | 2.4% | 1.2% |
现金转化率GPCHSIC
| Q1 26 | — | — | ||
| Q4 25 | — | 3.77× | ||
| Q3 25 | 1.51× | 1.72× | ||
| Q2 25 | 0.82× | 1.40× | ||
| Q1 25 | -0.21× | 0.34× | ||
| Q4 24 | 1.17× | 2.17× | ||
| Q3 24 | 2.14× | 1.53× | ||
| Q2 24 | 0.99× | 2.85× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GPC
暂无分部数据
HSIC
| Global Dental Merchandise | $1.2B | 35% |
| Global Medical | $1.1B | 31% |
| Global Dental Equipment | $536.0M | 16% |
| Global Specialty Products | $422.0M | 12% |
| Global Technology | $173.0M | 5% |
| Global Value Added Services | $64.0M | 2% |
| Equity Method Investee | $14.0M | 0% |
